1. Home
  2. PHAT vs NPK Comparison

PHAT vs NPK Comparison

Compare PHAT & NPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAT
  • NPK
  • Stock Information
  • Founded
  • PHAT 2018
  • NPK 1905
  • Country
  • PHAT United States
  • NPK United States
  • Employees
  • PHAT N/A
  • NPK N/A
  • Industry
  • PHAT Biotechnology: Pharmaceutical Preparations
  • NPK Ordnance And Accessories
  • Sector
  • PHAT Health Care
  • NPK Industrials
  • Exchange
  • PHAT Nasdaq
  • NPK Nasdaq
  • Market Cap
  • PHAT 820.8M
  • NPK 785.7M
  • IPO Year
  • PHAT 2019
  • NPK N/A
  • Fundamental
  • Price
  • PHAT $11.66
  • NPK $112.37
  • Analyst Decision
  • PHAT Strong Buy
  • NPK
  • Analyst Count
  • PHAT 5
  • NPK 0
  • Target Price
  • PHAT $16.40
  • NPK N/A
  • AVG Volume (30 Days)
  • PHAT 1.1M
  • NPK 43.8K
  • Earning Date
  • PHAT 11-06-2025
  • NPK 11-07-2025
  • Dividend Yield
  • PHAT N/A
  • NPK 0.89%
  • EPS Growth
  • PHAT N/A
  • NPK 26.27
  • EPS
  • PHAT N/A
  • NPK 5.82
  • Revenue
  • PHAT $114,039,000.00
  • NPK $450,603,000.00
  • Revenue This Year
  • PHAT $207.52
  • NPK N/A
  • Revenue Next Year
  • PHAT $96.46
  • NPK N/A
  • P/E Ratio
  • PHAT N/A
  • NPK $18.83
  • Revenue Growth
  • PHAT 1049.82
  • NPK 31.27
  • 52 Week Low
  • PHAT $2.21
  • NPK $69.80
  • 52 Week High
  • PHAT $19.71
  • NPK $113.19
  • Technical
  • Relative Strength Index (RSI)
  • PHAT 54.88
  • NPK 65.73
  • Support Level
  • PHAT $11.89
  • NPK $108.26
  • Resistance Level
  • PHAT $13.00
  • NPK $111.15
  • Average True Range (ATR)
  • PHAT 0.71
  • NPK 2.95
  • MACD
  • PHAT -0.11
  • NPK 0.46
  • Stochastic Oscillator
  • PHAT 26.57
  • NPK 87.51

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

About NPK National Presto Industries Inc.

National Presto Industries Inc has an eclectic product portfolio consisting of household appliances, ammunition, and diapers. The company operates in three segments namely Defense, Housewares/Small Appliance, and Safety. The defense segment which is engaged in manufacturing 40mm ammunition, precision mechanical and electro-mechanical assemblies, and medium caliber cartridge cases; performs Load, Assemble, and Pack (LAP) operations on ordnance-related products for the U.S. Government and prime contractor. While Housewares/Small Appliance segment designs, markets, and distributes housewares and small electrical appliances; the safety segment provides safety technology empowering organizations and individuals to protect what is more important.

Share on Social Networks: